A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
16 Nov 2023
Historique:
received: 13 09 2023
medline: 20 11 2023
pubmed: 20 11 2023
entrez: 20 11 2023
Statut: aheadofprint

Résumé

High-dose melphalan plus autologous stem-cell transplantation (ASCT) is a standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM), and adequate hematopoietic stem-cell (HSC) collection is crucial to ensure hematologic recovery after ASCT. In this prospective, observational study we evaluated HSC mobilization with granulocyte colony-stimulating factor (G-CSF), cyclophosphamide, and 'on-demand' plerixafor (in patients with.

Identifiants

DOI: 10.3324/haematol.2023.284023 PMID: 37981892
pubmed: 37981892
doi: 10.3324/haematol.2023.284023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Roberto Mina (R)

Division of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino. roberto.mina@unito.it.

Maria Teresa Petrucci (MT)

Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.

Francesca Bonello (F)

Medical Oncology Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo.

Velia Bongarzoni (V)

U.O.C. Ematologia, Azienda Ospedaliera "San Giovanni/Addolorata", Roma.

Riccardo Saccardi (R)

Cellular Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence.

Giuseppe Bertuglia (G)

Division of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino.

Andrea Mengarelli (A)

Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome.

Andrea Spadaro (A)

Division of Hematology, AOU Policlinico, University of Catania.

Chiara Lisi (C)

Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.

Paola Curci (P)

Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari.

Roberto Massimo Lemoli (RM)

Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genova, Italy; IRCCS Policlinico San Martino, Genova.

Stelvio Ballanti (S)

Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, localita Sant'Andrea delle Fratte, Perugia.

Rita Floris (R)

S.C. Ematologia e CTMO, Ospedale Oncologico "A. Businco", Cagliari.

Luca Cupelli (L)

Department of Hematology, S. Eugenio Hospital, Rome.

Patrizia Tosi (P)

Hematology Unit, Infermi Hospital, Rimini.

Attilio Olivieri (A)

Clinica di Ematologia, Azienda Ospedaliero Universitaria delle Marche, Ancona.

Delia Rota-Scalabrini (D)

Medical Oncology Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo.

Clotilde Cangialosi (C)

U.O.C. Ematologia, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo.

Chiara Nozzoli (C)

Cellular Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence.

Barbara Anaclerico (B)

U.O.C. Ematologia, Azienda Ospedaliera "San Giovanni/Addolorata", Roma.

Francesca Fazio (F)

Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome.

Benedetto Bruno (B)

Division of Hematology, AOU Citta della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino.

Katia Mancuso (K)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seragnoli", Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Universita di Bologna, Bologna.

Paolo Corradini (P)

Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Universita di Milano, Milano.

Giuseppe Milone (G)

Division of Hematology, AOU Policlinico, University of Catania.

Mario Boccadoro (M)

Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino.

Classifications MeSH